RhumbLine Advisers’s Eterna Therapeutics ERNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-85
Closed -$52K 3140
2022
Q1
$52K Buy
85
+26
+44% +$15.9K ﹤0.01% 2970
2021
Q4
$74K Hold
59
﹤0.01% 2963
2021
Q3
$165K Buy
59
+10
+20% +$28K ﹤0.01% 2939
2021
Q2
$263K Buy
+49
New +$263K ﹤0.01% 2833